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Abstract  
BACKGROUND: Moderate sedation for gastrointestinal endoscopy has traditionally been provided 
by the endoscopist. Controversy has ensued over safe and efficient sedation practice as endoscopy 
has increased in numbers and complexity. 
AIM: To evaluate the safety of ketamine sedation given by non-anesthesiologist during 
gastrointestinal endoscopy in children. 
METHODS: A prospective study of 100 paediatric patients with gastrointestinal symptoms who 
were a candidate for upper or lower gastrointestinal endoscopy in paediatric endoscopy unit at Abo 
El-Reesh paediatric hospital, Cairo university. All children were > 2 years old and weighed > 6 kg. 
The analysis was performed in terms of sedation-related complications. 
RESULTS: A total 100 paediatric patients including 53 males and 47 females with mean age of 
5.04 years were involved in the study. All children were medicated with ketamine with a mean dose 
of 3.77mg/kg. No complications occurred in 87% of cases. Desaturation occurred in 13% of the 
cases and was reversible by supplemental nasal oxygen. Desaturation was more frequent during 
Upper GI Endoscopy and with the intramuscular route (p value=0.049). No apnea, bradycardia, 
arrest or emergence reactions were recorded. 
CONCLUSION: Ketamine sedation found to be safe for paediatric gastrointestinal endoscopy in 
Egyptian children without co-morbidities. Transient Hypoxia (13%) may occur but easily reversed by 
nasal oxygen therapy. 
 
 
 
Introduction 
 
Although gastrointestinal endoscopy is widely 
accepted as fundamental to the diagnosis and 
treatment of digestive disorders in children, 
considerable controversy and practice differences 
persist with respect to the methods and agents used 
to achieve optimal endoscopic sedation [1]. Sedation 
must have a rapid onset, short duration of action, and 
should be safely administered by a non-
anesthesiologist without significantly increased the 
risk of potential complications [2]. 
Ketamine is a general anaesthetic agent 
widely used for paediatric procedural sedation outside 
the operating theatre by non-anesthesiologists [3].
 
It is 
considered a dissociative anaesthetic. This means 
that the drug distorts the user's perception of sight and 
sound and produces feelings of detachment from 
the environment and one's self [4].
 
Ketamine has 
found many applications in paediatric anaesthetic 
practice. Insights into the mechanism of action and 
the pharmacokinetics and pharmacodynamics of its 
isomers have led to a re-evaluation of this drug, 
expanding the range of applications in children. 
Ketamine is a remarkably versatile drug that can be 
administered through almost any route. It can also be 
used for different purposes [5]. 
Prior studies of ketamine sedation for 
paediatric gastrointestinal endoscopy have been 
retrospective in nature and have used chart review to 
identify any clinical concerns for inadequate sedation 
[6, 7]. 
The aim of the present study was to 
evaluate the safety of ketamine sedation given by 
non-anesthesiologist during upper and lower 
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gastrointestinal endoscopy in children. Also, this study 
aims to detect possible complications from sedation 
in the upper and lower gastrointestinal endoscopy in 
children and relation between the disease history 
and clinical condition of the patient with possible 
complications of sedation by ketamine. 
 
 
Patients and Methods 
 
This prospective study was conducted upon 
100 paediatric   patients  with gastrointestinal 
symptoms who were a candidate for upper or lower 
gastrointestinal endoscopy presented to Pediatric 
Endoscopy Unit, Abo El-Reesh Pediatric Hospital, 
Cairo University. 
All patients had the appropriate instructions 
for gastrointestinal endoscopy according to its type. 
The study followed the regulations of the 
medical ethical committee of  Abo El-Reesh Pediatric 
Hospital, Cairo University and written Informed 
consent was obtained from the appropriately 
designated parent or guardian. 
A full and detailed history was taken from one 
of the parents or guardians regarding the disease, 
nutritional and drug history including drug allergies.  
A full clinical examination of the patient was 
done including general, cardiac, chest and abdominal 
examination. 
Pre-sedation risk assessment of 
cardiopulmonary status including heart rate, 
respiratory rate, oxygen saturation and blood pressure 
measurement was done before ketamine 
administration. 
 
Ketamine Administration 
 Intravenous (IV) Route: A loading dose of 1.5 
to 2 mg/kg was administrated. The procedure 
started 30 seconds to 1 minute after 
administration. Additional incremental doses 
of ketamine may be administered (0.5 to 1 
mg/kg) if initial sedation was inadequate or to 
accomplish a longer procedure. 
 Intramuscular (IM) Route: Ketamine was 
administrated with a dose of 3 to 5 mg/kg. 
Clinical onset began within 5 minutes. 
Duration of effective dissociation was 20 to 30 
minutes. 
Sedation was actively administered and 
supervised by a paediatrician. Procedures were 
performed by four different endoscopists and also 
attended by two nurses educated in sedation 
pharmacology and gastrointestinal endoscopy. 
Constant patient monitoring during and after the 
administration of ketamine was provided including 
continuous cardiac monitoring, respiratory rate, pulse 
oximetry and blood pressure monitoring. 
Sedation-related complications include a drop 
in oxygen saturation to equal or less than 94%, 
respiratory distress (stridor or wheezes), apnea, 
bradycardia (< 60 beats per minute), cardiac arrest, 
emergency reactions and need for reversal 
medication were observed. All patients were put under 
observation for 2 hours after the procedure to observe 
any complications. 
 
Statistical analysis 
Statistical analysis was performed using the 
SPSS statistical package software for windows 
version 21 (SSPS Inc, Pennsylvania, USA). 
Parametric variables are expressed as the mean ± 
SD. P value <0.05 was considered significant. 
 
 
Results 
 
The patients included 53 males (53%) and 47 
females (47%).Their age ranged from 2 to 12 years 
with a mean of 5.04 years, while their weight ranged 
from 6 to 36 kg with a mean of 16.92 kg and they 
received ketamine with a dose ranged from 2 to 5 
mg/kg with a mean of 3.77 mg/kg (Table 1). 
Table 1: Ketamine doses in studied cases 
 Mean ± SD Median Minimum Maximum 
Age (years) 5.04 ± 3.120 4.50 2 12 
Weight (kg) 16.92 ±7.388 15.00 6 36 
Ketamine dose (mg/kg) 3.77 ± 0.851 4.00 2 5 
 
 
Most of the studied cases (42%) were 
indicated for GI endoscopy for diagnostic purposes, 
while 24 cases (24%) were done for follow-up of 
oesophagal varies, 1 case (1%) was done routinely 
before renal transplantation (Table 2). 
Table 2: Indications of endoscope in studied cases 
 Frequency(No) Percent (%) 
Dilatation 23 23 
Diagnostic 42 42 
Foreign body extraction 10 10 
Follow-up of oesophagal varices 24 24 
Routine before renal transplantation 1 1 
Total 100 100 
 
 
In pre-sedation assessment and examination, 
we found 3 cases with tachycardia and 4 cases with 
hypertension for age, 2 cases with cardiac murmur, 4 
cases with wheezy chest and respiratory distress, 5 
cases with ascites and there was no significant 
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relation between these findings and occurrence of 
complications except for those who had respiratory 
distress, all of them developed hypoxia during the 
procedure (p value=0.001) 
The only complication that occurred in our 
study was desaturation; there were 13 patients who 
developed hypoxia during the procedure. These 
patients developed a decrease in oxygen saturation to 
less than 94% by pulse oximetry. These attacks of 
hypoxia were easily reversed by supplemental nasal 
oxygen. 
In our study, Cases are classified into four 
groups according to the type of the procedure 
performed (Upper GI endoscopy, Colonoscopy) and 
the route of ketamine administration (IM, IV) 
Group (1) had upper GI endoscopy and 
received ketamine intravenously. Group (2) had upper 
GI endoscopy and received ketamine intramuscularly. 
Group (3) had a colonoscopy and received ketamine 
intravenously. Group (4) had a colonoscopy and 
received ketamine intramuscularly. 
There was a significant relation between the 
route of ketamine administration and type of 
performed procedure with occurrence of 
complications, hypoxia occurred during Upper GI 
Endoscopy (14.28%) more than that occurred during 
lower GI Endoscopy (8.69%) and with the 
intramuscular administration of ketamine (15.38%) 
more than the intravenous (8.57%) (p value=0.49), 
(Table 3). 
Table 3: Classification of studied cases according to the 
type of the procedure performed (Upper GI endoscopy, 
Colonoscopy) and the route of ketamine administration (IM, IV) 
 Group 1 Group 2 Group 3 Group 4 P value 
 NO % NO % NO % NO %  
Hypoxia 3 11.1 8 16 0 0 2 13.3 0.049 
Normal 24 88.9 42 84 8 100 13 86.7 
 
 
There was no relation between ketamine dose 
and occurrence of complications. After the procedure, 
one of the studied cases had an attack of vomiting 
that didn’t recur. 
 
 
Discussion 
 
This prospective study was designed to 
detect complications of ketamine sedation given by 
non-anesthesiologist in gastrointestinal endoscopy in 
children. A total of 100 cases presented to the 
Gastrointestinal Endoscopy Unit of Abo El-Reesh 
Pediatric hospital. 
In our study, there were 13 patients who 
developed hypoxia during the procedure and it was 
reversed by supplemental oxygen. These patients 
developed a decrease in oxygen saturation to less 
than 94% by a pulse oximeter. Most of these patients 
developed desaturation within few minutes from the 
introduction of the endoscopy. This desaturation is 
thought to be due to laryngospasm. Although 
ketamine has been deemed safe based on it's 
cardiovascular and respiratory protective effect [6, 7]
 
it 
is also associated with increased risk of laryngospasm 
[9, 10]. 
Most of the episodes of desaturation occurred 
during Upper GI Endoscopy (14.28%), where 
stimulation of the posterior pharynx may increase 
the risk of airway complications. Desaturation also 
occurred more frequent with the Intramuscular route 
(15.38%), so Desaturation was more frequent in the 
group (2) (16%) than group (1) (11.1%). 
All patients who had respiratory distress by 
examination before injection of ketamine had hypoxia 
during the procedure (p value=0.001). 
The study was done by Green and Johnson, 
1990 [11]
 
of 11,589 patients, the incidence of 
laryngospasm was 0.4%, and that when it did occur, 
it was easily treated, only two cases of ketamine-
associated laryngospasm led to intubation. 
Unlike to our study, the incidence of 
desaturation less than 94% was 13%, but destruction 
may be due to laryngospasm or other causes 
related (Increased bronchial secretions) or not 
related to ketamine sedation such as associated chest 
infection as all patients who had respiratory distress 
and wheezy chest by examination before injection of 
ketamine developed desaturation during procedure. 
In our study, none of the patients developed 
apnea, bradycardia or arrest. In our study, none of the 
patients developed emergence reactions, this may be 
due to young age of the sample size that ranged from 
2 to 12 years with mid age of 5 years and these 
reactions, unpleasant dreams or hallucinations are 
mainly found to be transient and mild in children [12], 
however recovery agitation occurred in (2.4%) in 
study done by Green and his colleagues, 2011 [13].
 
Ketamine was found to increase heart rate 
nearly for all children more than that measured before 
injection in pre-sedation assessment, but it was 
accepted for their age. 
Also, ketamine was found to increase blood 
pressure nearly for all children more than that 
measured before in the pre-sedation assessment, 
but most of them were accepted for their age. 
Hypertension occurred above-accepted level for age 
in 4 cases (4%), 2 of them was in group (4) who had 
high blood pressure in pre-sedation assessment 
before ketamine injection, one in group (1), this 
patient was previously diagnosed with ITP and 
received steroids, and one in group (2), this patient 
was Steroid Resistant Nephrotic Syndrome (SRNS), 
receiving steroids and the endoscopy was requested 
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as a routine preparation of renal transplantation. 
In all groups, there is no relation between 
ketamine dose and complications except in group (3), 
this could not be assessed as there is no 
complications occurred in this group. 
One patient (1%) in the group (2) developed 
post-procedural vomiting, this female patient is SRNS, 
was receiving steroids, received ketamine at a dose of 
2.5 mg/kg, had high blood pressure for her age during 
the procedure and her upper GI endoscopy revealed 
gastritis. 
A randomised clinical trial suggested that 
the use of 0.01 mg/kg of atropine reduced 
hypersalivation and vomiting associated with IM 
ketamine; there are no data on this strategy when 
used with IV ketamine [14]. 
A study was done by Green et al., 2011 [13]
 
which is different from our study as it was 
retrospective in 636 cases primarily by the 
intravenous (IV) route (98%), but our study is 
prospective study on 100 cases primarily on the 
intramuscular (IM) route (65%). 
This study is similar to our study as it was 
done primarily for EGD (86%) and our study was 
done also primarily for EGD (76%). 
Adverse effects of this study included 
transient laryngospasm (8.2%), vomiting (4.1%), 
recovery agitation (2.4%), partial airway obstruction 
(1.3%), apnea and respiratory depression (0.5%), and 
excessive salivation (0.3%) and this differs 
completely from our study as we had desaturation 
(13%),vomiting(1%) with no other adverse effects 
but it may be due to this study had nearly half (46%) 
the subjects had severe underlying illness (American 
Society of Anesthesiologists (ASA] class > or =3) and 
our study had exclusion criterion of any severe 
illness. 
In this study, all instances of laryngospasm 
occurred during EGD (9.5% incidence), and the only 
independent predictor of laryngospasm in this sample 
was decreasing age. The incidence of laryngospasm 
was 13.9% in preschool-aged (< or = 6 years) 
children and was 3.6% in school-aged (> 6 years) 
children (difference 10.3%, 95% confidence intervals 
5.5-14.9%). No dose relationship was noted with 
laryngospasm. This is similar to our study as 
desaturation occurred mainly in EGD (14%) and there 
is no relation between ketamine dose and 
desaturation but differs that no relations between age 
and desaturation in our study. 
In Regional Hospital of Iquique, Iquique, 
Chile, over the past 24 years, with the authorization 
of the anesthesiology department, they have used 
ketamine in more than 900 paediatric endoscopic 
procedures. This experience has included upper 
endoscopy, intestinal biopsy, colonoscopy, 
percutaneous gastrostomy, ERCP, foreign-body 
removal, oesophagal dilation, and oesophagal 
sclerotherapy [15].  
These indications are similar to our 
indications which included upper endoscopy for 
diagnosis and follow-up, colonoscopy (23%), foreign 
body removal (10%), oesophagal dilation (23%), and 
routine before Renal Transplantation. 
Our data may be useful for planning larger 
studies required to determine whether laryngospasm 
or other adverse events occurs more or less 
frequently with ketamine than has been reported 
previously. 
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